microPublication

Get Your Data Out, Be Cited

  • About
    • Editorial Policies
      • Editorial Staff
      • Editorial Board
      • Criteria For Publication
      • Publishing Information
      • Data Sharing Policy
    • For Authors
      • Preparation And Submission Of A Manuscript
      • Peer Review Process
      • Following Acceptance
      • Appeals
    • For Reviewers
    • Why micropublish?
  • Submit a microPublication
  • Journals
    • microPublication Biology
      • Editorial Board
  • microPublications
    • Biology
      • Species
        • Arabidopsis
        • C. elegans
        • D. discoideum
        • Drosophila
        • Human
        • Mouse
        • S. cerevisiae
        • S. pombe
        • Xenopus
        • Zebrafish
      • Categories
        • Phenotype Data
        • Methods
        • Expression Data
        • Genotype Data
        • Integrations
        • Genetic Screens
        • Models of Human Disease
        • Software
        • Interaction data
        • Database Updates
        • Electrophysiology Data
        • Phylogenetic Data
        • Science and Society
        • Biochemistry
  • Contact
  • More
    • Archives
    • FAQs
    • Newsletter
microPublication / Biology / Individual point mutations in two...
Individual point mutations in two ERAD E2 ubiquitin-conjugating enzymes do not affect Caenorhabditis elegans spontaneous reversal frequency
Mackenzi Oswald1, Heino Hulsey-Vincent1 and Caroline (Lina) Dahlberg1
1Department of Biology, Western Washington University, Bellingham, WA, 98225, USA
Correspondence to: Caroline (Lina) Dahlberg (lina.dahlberg@wwu.edu)
Figure 1. Mutations in E2 ubiquitin-conjugating enzyme genes and glr-1 affect spontaneous reversal frequencies differently: A. Spontaneous reversal frequency assays were performed using wild type (WT) C. elegans, alongside strains harboring mutations in glr-1 or in genes that encode the E2 ubiquitin-conjugating enzymes, ubc-6 and ubc-7. Box and whisker plots show the average reversals per minute, bounded by quartiles; the line in each box represents the median of the average reversals per minute for each genotype. N=20 individual animals for all genotypes; significance relative to WT was calculated using the Tukey-Kramer test following a one-way ANOVA (*, p=0.0027 for glr-1; non-significant: p=0.58 for ubc-6; p=0.48 for ubc-7). The data is normally distributed (Shapiro-Wilk test, p=0.86) and groups show equal variance (residuals vs. fitted plot). B. Schematics of E2 ubiquitin-conjugating enzyme genes and glr-1 gene, including the locations of point mutations. Schematics were made using http://wormweb.org/exonintron. C. Crystal structures of the human E2 Ube2j2 (top, with rotated view to show the back side of the protein) and Ube2g2 (bottom, left). Models were made using Pymol. Residues that are mutated are shown in red (Ube2j2, D153; UBC-6, T158) and yellow (Ube2g2, P78, UBC-7, P79). Residue F156 of Ube2j2 is shown in cyan. Alignments of C. elegans UBC-6 and UBC-7 regions of homology, compared to putative orthologs in other eukaryotes. The highlighted residues correspond to those shown in the structures.

Description

Maintaining proteostasis, or protein homeostasis, is an important cellular function because misfolded proteins can aggregate and contribute to neurodegenerative diseases. One way that cells preserve proteostasis is through the Endoplasmic Reticulum Associated Degradation pathway (ERAD). ERAD relies on interactions between E2 ubiquitin-conjugating enzymes and E3 ubiquitin ligases to ubiquitylate misfolded proteins in order to signal for their destruction via the proteasome (Vembar and Brodsky 2008). We investigated if missense mutations in genes that encode two E2 ubiquitin-conjugating enzymes in C. elegans, UBC-6 and UBC-7, affect spontaneous reversal frequency (Brockie et al. 2001; Jones et al. 2002; Stewart et al. 2016; Zheng et al. 1999).

UBC-6 and UBC-7 are conserved across Eukaryotes (Figure 1C). We obtained strains of animals from the Million Mutation Project with the missense mutations that confer the amino acid changes T158I in UBC-6 and P79L in UBC-7. The analogous residues in human Ube2j1 or Ube2j2 and Ube2g2 are Asp160 or 153 and Proline 78, respectively, which were mapped onto the available structures of the human enzymes (Figure 1C). In Ube2j2 (C. elegans UBC-6) Asp153 makes contact with Phe156, and mutating this residue decreases the efficiency of the enzyme (Tobi Ritterhoff, personal communication). Structural alignments suggest that Pro78 (mutated in UBC-7) is part of the well-conserved HPN (Histadine-Proline-Asparagine) motif, so mutation of the analogous residue was hypothesized to abrogate enzymatic activity (Cook and Shaw 2012; Wu et al. 2003).

Our results show that the E2 ubiquitin-conjugating enzyme mutations did not significantly affect C. elegans spontaneous reversal frequency (Figure 1A). glr-1 animals were used as a control and reversed significantly less frequently than wild-type animals, as previously reported (Kowalski et al. 2011). Both ubc-6 and ubc-7 animals had less frequent spontaneous reversals than WT animals and more frequent spontaneous reversals than glr-1 animals, but neither of these results were significant.

One clear reason for the insignificant change in reversal frequency in the ubc-6 and ubc-7 mutant animals could be that the missense mutations in these strains we observed do not affect gene function. It is also possible that UBC-6 and UBC-7 are able to compensate for each other in C. elegans. In S. cerevisiae Ubc6p and Ubc7p work cooperatively and sequentially to target substrates in coordination with the E3 ligases Doa10p (orthologous to C. elegans MARC-6), and Hrd1p (orthologous to C. elegans HRD-1 and paralogous to HRDL-1) (Sasagawa et al. 2007; Weber et al. 2016). It could be that this mechanism of tandem ubiquitylation is not conserved in C. elegans despite its conservation for human UBE2J2 (Weber et al. 2016). The human orthologs HRD1 and UBE2J1 (an additional ortholog of Ubc6p) also work together to target substrate proteins for degradation (Bays et al. 2001; Burr et al. 2011). Therefore it is possible that C. elegans E3s could collaborate with either UBC-6 or UBC-7 to target substrate proteins for degradation. In the future, we plan to address these possibilities using double ubc-6; ubc-7 point mutants and CRISPR-Cas9-targeted deletion mutants for UBC-6 and UBC-7, in combination with E3 ligase mutants.

Methods

Request a detailed protocol

Reversal assay protocol: Each C. elegans strain was grown on separate NGM agar plates seeded with OP50, at 21.4°C. While setting up for the reversal assays, multiple young adult hermaphroditic nematodes from each strain were picked onto separate seeded NGM agar plates and coded. This allows for blind analysis of the videotaped trials to occur when scoring the reversal assays, in order to reduce potential bias. During the assay, one animal at a time was picked using halocarbon oil (a non-food substance) from its coded seeded plate onto an unseeded NGM agar plate to induce food-seeking behavior. The animal was allowed to move around for two minutes before videotaping began. If the animal did not move away from its initial position after two minutes it was discarded and not counted in the data set. Each animal was recorded for five minutes and then discarded. At least one individual of each strain was observed during each experimental session in order to allow for any potential variations in temperature and humidity to be accounted for equally across all strains. The total N values listed represent measurements from multiple experimental sessions.

Scoring reversals: After finishing recording all reversal assay trials for an experiment, the coded trials were viewed and scored blindly by one researcher. Movement was counted as a reversal if the tip of the nose moved backwards for at least 1/6th of the animal’s body length. The position of the posterior pharyngeal bulb was used as a marker for that distance.

Recording setup: An Olympus SZ61 microscope attached to a TLB 4000 Series Substage Illuminator base was used to record the videos. The microscope was connected to The Imaging Source DFK 31AF03 color camera, which was connected to a computer running Windows OS. The software used to record the videos was Debut Professional by NCH Software.

Genotyping: The genotypes of all strains were confirmed after completing the trials. The genotypes of KP4, CLD41 and CLD43 were confirmed using PCR and DNA sequencing.

Additional point mutations from the MMP were considered for these experiments (http://genome.sfu.ca/gexplore/) but only one other available allele (ubc-6 (gk549681)) was also predicted to have an effect on enzyme function (Tobi Ritterhoff, personal communication). Although that strain was viable, we were unable to backcross it to remove background mutations. Other existing deletion mutants remove sequences outside of the coding locus of each gene. We also note that following our experiments, CRISPR-Cas9-targeted deletion mutants became available for each gene, but these were not available for use at the time of this study.

Reagents

Table 1. C. elegans strains used.

Strain Name Genotype Description Reference
N2 Wild-type
KP4 glr-1(n2461) III glr-1 putative knockout, nonsense point mutation Hart AC et al. 1995
CLD41 ubc-6(gk146975) II*5 E2 ubiquitin- conjugating enzyme putative reduction-of-function, missense mutation, backcrossed 5 times Thompson O et al. 2013
CLD43 ubc-7(gk857464) III*5 E2 ubiquitin-conjugating enzyme putative reduction-of-function, missense mutation, backcrossed 5 times Thompson O et al. 2013

Acknowledgments

We thank the students of Western Washington University’s Biology 487 course (Spring 2020) and Dr. Jacqueline Rose for critical readings of this manuscript.

References

Bays NW, Gardner RG, Seelig LP, Joazeiro CA, Hampton RY. 2001. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat Cell Biol 3: 24-9.
PubMed
Brockie PJ, Mellem JE, Hills T, Madsen DM, Maricq AV. 2001. The C. elegans glutamate receptor subunit NMR-1 is required for slow NMDA-activated currents that regulate reversal frequency during locomotion. Neuron 31: 617-30.
PubMed
Burr ML, Cano F, Svobodova S, Boyle LH, Boname JM, Lehner PJ. 2011. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc Natl Acad Sci U S A 108: 2034-9.
PubMed
Cook BW, Shaw GS. 2012. Architecture of the catalytic HPN motif is conserved in all E2 conjugating enzymes. Biochem J 445: 167-74.
PubMed
Hart AC, Sims S, Kaplan JM. 1995. Synaptic code for sensory modalities revealed by C. elegans GLR-1 glutamate receptor. Nature 378: 82-5.
PubMed
Jones D, Crowe E, Stevens TA, Candido EP. 2002. Functional and phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans: ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-like proteins. Genome Biol 3: RESEARCH0002.
PubMed
Kowalski JR, Dahlberg CL, Juo P. 2011. The deubiquitinating enzyme USP-46 negatively regulates the degradation of glutamate receptors to control their abundance in the ventral nerve cord of Caenorhabditis elegans. J Neurosci 31: 1341-54.
PubMed
Sasagawa Y, Yamanaka K, Ogura T. 2007. ER E3 ubiquitin ligase HRD-1 and its specific partner chaperone BiP play important roles in ERAD and developmental growth in Caenorhabditis elegans. Genes Cells 12: 1063-73.
PubMed
Stewart MD, Ritterhoff T, Klevit RE, Brzovic PS. 2016. E2 enzymes: more than just middle men. Cell Res 26: 423-40.
PubMed
Thompson O, Edgley M, Strasbourger P, Flibotte S, Ewing B, Adair R, Au V, Chaudhry I, Fernando L, Hutter H, Kieffer A, Lau J, Lee N, Miller A, Raymant G, Shen B, Shendure J, Taylor J, Turner EH, Hillier LW, Moerman DG, Waterston RH. 2013. The million mutation project: a new approach to genetics in Caenorhabditis elegans. Genome Res 23: 1749-62.
PubMed
Vembar SS, Brodsky JL. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol 9: 944-57.
PubMed
Weber A, Cohen I, Popp O, Dittmar G, Reiss Y, Sommer T, Ravid T, Jarosch E. 2016. Sequential Poly-ubiquitylation by Specialized Conjugating Enzymes Expands the Versatility of a Quality Control Ubiquitin Ligase. Mol Cell 63: 827-39.
PubMed
Wu PY, Hanlon M, Eddins M, Tsui C, Rogers RS, Jensen JP, Matunis MJ, Weissman AM, Wolberger C, Pickart CM. 2003. A conserved catalytic residue in the ubiquitin-conjugating enzyme family. EMBO J 22: 5241-50.
PubMed
Zheng Y, Brockie PJ, Mellem JE, Madsen DM, Maricq AV. 1999. Neuronal control of locomotion in C. elegans is modified by a dominant mutation in the GLR-1 ionotropic glutamate receptor. Neuron 24: 347-61.
PubMed

Funding

Partial funding was provided by a Research and Creative Opportunities Grant for Undergraduate Students from the Office of Research & Sponsored Programs at Western Washington University.

Author Contributions

Mackenzi Oswald: Formal analysis, Funding acquisition, Investigation, Writing - original draft, Writing - review and editing, Methodology
Heino Hulsey-Vincent: Formal analysis, Visualization, Writing - review and editing
Caroline (Lina) Dahlberg: Conceptualization, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing - review and editing.

Reviewed By

Eric Luth and Anonymous

History

Received: June 2, 2020
Revision received: November 9, 2020
Accepted: November 10, 2020
Published: November 19, 2020

Copyright

© 2020 by the authors. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Oswald, M; Hulsey-Vincent, H; Dahlberg, C( (2020). Individual point mutations in two ERAD E2 ubiquitin-conjugating enzymes do not affect Caenorhabditis elegans spontaneous reversal frequency. microPublication Biology. 10.17912/micropub.biology.000328.
Download: RIS BibTeX
microPublication Biology is published by
1200 E. California Blvd. MC 1-43 Pasadena, CA 91125
The microPublication project is supported by
The National Institute of Health -- Grant #: 1U01LM012672-01
microPublication Biology:ISSN: 2578-9430